Germany Hemodialysis Equipment Market Report 2023 to 2030

Germany Hemodialysis Equipment Market Analysis

$ 3999

The Germany Hemodialysis Equipment Market was valued at $516.8 Mn in 2023 and is projected to grow at a CAGR of 5.8% from 2023 to 2023, to $766.9 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Diamed Medizintechnik GmbH, Siemens Healthineers AG, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, among others.

ID: IN10DEMD018 CATEGORY: Medical Devices GEOGRAPHY: Germany AUTHOR: Mahima Reddy

Buy Now

Germany Hemodialysis Equipment Market Executive Summary

The Germany Hemodialysis Equipment Market is at around $516.8 Mn in 2023 and is projected to reach $766.9 Mn in 2030, exhibiting a CAGR of 5.8% during the forecast period 2023-2030.

Hemodialysis is a critical treatment for patients with end-stage renal disease, and it relies on specialized medical devices to function effectively. The main components of a haemodialysis machine include the dialyzer (artificial kidney), blood pump, dialysate pump, air detector, heparin pump, temperature monitor, and conductivity monitor.

The dialyzer is a filter that removes waste and excess fluid from the blood. The blood pump pulls blood from the body into the dialyzer, while the dialysate pump sends a special fluid into the dialyzer to help remove the waste and fluid. The air detector monitors for air bubbles in the blood line and stops the blood pump if air is detected to prevent air embolism. The heparin pump delivers an anticoagulant into the blood to prevent clotting during the dialysis process. The temperature monitor ensures the dialysate remains within a safe temperature range, and the conductivity monitor checks the concentration of electrolytes in the dialysate. These various components work together as part of the hemodialysis machine to filter the patient's blood, maintain the proper fluid and electrolyte balance, and prevent complications. Advancements in dialysis technology have helped improve the safety and efficacy of this life-saving treatment.

The number of people receiving dialysis treatment in Germany reached 93,000 in 2021, a 2.2% increase from 2020 and Germany has an aging population, with the number of adults aged 65 and older projected to reach 23.2 million by 2030. The hemodialysis market is driven by significant factors like aging population, increase prevalence rate of chronic diseases, increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth.

B. Braun is a German medical and pharmaceutical device company that is a key player in the hemodialysis market. The company offers a wide range of hemodialysis products, including machines, dialyzers, bloodlines, and other consumables. In 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates, to enhance its R&D capabilities for hemodialysis.

Germany Hemodialysis Equipment Market Report 2023 to 2030

Market Dynamics

Market Drivers

Aging Population: Germany has an aging population, with the number of adults aged 65 and older projected to reach 23.2 Mn by 2030. The risk of chronic kidney disease increases with age, leading to higher demand for dialysis treatments in the elderly population.

Increasing Prevalence of Chronic Kidney Disease: The number of people receiving dialysis treatment in Germany reached 93,000 in 2021, a 2.2% increase from 2020. The rising prevalence of chronic conditions like diabetes and hypertension, which are major risk factors for chronic kidney disease, is driving the demand for hemodialysis.

Strong Healthcare Infrastructure: Germany has a strong healthcare system with well-developed infrastructure, including a large number of dialysis centres and hospitals equipped with advanced dialysis equipment. This infrastructure supports the delivery of high-quality dialysis care to patients.

Market Restraints

High Cost of Dialysis Treatments: The average cost of hemodialysis in Germany is around €50,000 per patient per year. The high cost of treatment can limit access to dialysis for patients without adequate insurance coverage or financial resources.

Regulatory Restrictions on Medical Care Centres: A draft bill in Germany proposes restrictions on providers of dialysis services, allowing them to set up and operate medical care centres (MVZs) only in the same area of specialization. This could limit the expansion potential of existing MVZ platforms and impact investment opportunities in the dialysis market.

Product Recalls: There have been several product recalls in the dialysis market due to health hazards and regulatory non-compliance issues. This has eroded patient and provider confidence, hindering market growth.

Regulatory Landscape and Reimbursement Scenario

In Germany, the regulation and reimbursement of hemodialysis medical devices operate within a highly structured healthcare system that combines statutory health insurance (SHI) with private health insurance (PHI). The regulatory framework for medical devices, including hemodialysis equipment, aligns with the European Union Medical Device Regulation (EU MDR), which Germany has implemented into national law. Regulation of hemodialysis devices falls under the purview of the Federal Institute for Drugs and Medical Devices (BfArM). Manufacturers must obtain CE marking for their devices, demonstrating compliance with EU safety, health, and environmental protection requirements. The German Institute of Medical Documentation and Information (DIMDI) maintains a database of registered medical devices.

Reimbursement for hemodialysis in Germany is primarily managed through the statutory health insurance system, which covers about 90% of the population. The remaining 10% are covered by private health insurance. The Federal Joint Committee (G-BA), the highest decision-making body of the joint self-government of physicians, dentists, hospitals and health insurance funds, plays a crucial role in determining which services are covered by statutory health insurance.

For hemodialysis, the reimbursement system operates on a fee-for-service basis within a budget cap. The National Association of Statutory Health Insurance Physicians (KBV) negotiates with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) to set reimbursement rates for dialysis services. These rates are typically updated annually and include the costs of equipment, supplies, and medical staff. Home hemodialysis is supported and reimbursed, with statutory health insurance covering the costs of equipment and supplies. The German Society for Nephrology (DGfN) provides guidelines for dialysis treatment, which influence reimbursement policies and clinical practice.

Quality assurance is an integral part of the German healthcare system. The Institute for Quality Assurance and Transparency in Healthcare (IQTIG) develops quality indicators for dialysis care, which can impact reimbursement through pay-for-performance schemes.

Dialysis centres in Germany can be operated by hospitals, private practices, or specialized dialysis chains. Regardless of the provider, reimbursement comes primarily through the statutory health insurance system. For new hemodialysis technologies, the Institute for Quality and Efficiency in Health Care (IQWiG) may conduct health technology assessments to evaluate clinical effectiveness and cost-efficiency. These assessments can influence G-BA decisions on coverage and reimbursement.

Competitive Landscape

Key Players

Here are some of the major key players in the Germany Hemodialysis Equipment Market:

Siemens Healthineers AG
Diamed Medizintechnik GmbH
Medtronic
Stryker
Koninklijke Philips N.V.
Fresenius Medical Care
Baxter International
B. Braun
Nipro Corporation
Nikkiso Co., Ltd.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Hemodialysis Equipment Market Segmentation

By Hemodialysis Type

Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis

By Product & Services

Equipment
Consumables
Dialysis Drugs
Services

By End Use

Home-based
Hospital-based

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.